Emergent wins $24 million BARDA contract modification

Emergent received a $24 million BARDA contract modification to supply additional doses of CYFENDUS for anthrax preparedness.Key Highlights:Original SEC Filing: Emergent BioSolutions Inc. [ EBS ] - 8-K - Sep. 01, 2026This is an AI-powered summary. It may contain inaccuracies.

Consider verifying impo…